NCT00679354 2018-08-01
Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
6 trialsNCT00112866 2017-06-14
Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00121238 2016-04-28
Cilengitide in Treating Patients With Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00082875 2013-06-05
Cilengitide in Treating Patients With Unresectable or Metastatic Melanoma
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00103337 2013-02-28
Cilengitide in Treating Patients With Metastatic Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00089388 2013-01-24
Cilengitide in Treating Patients With Acute Myeloid Leukemia
National Cancer Institute (NCI)
Phase 2 Terminated